Ruchika Bhardwaj
Affiliations: | 2012- | Biosciences and Bioengineering | Indian Institute of Technology Guwahati |
Google:
"Ruchika Bhardwaj"Mean distance: (not calculated yet)
Parents
Sign in to add mentorVikash Dubey | research assistant | 2011-2012 | Indian Institute of Technology Guwahati | |
(completed M.Tech Project) | ||||
Vikash Dubey | grad student | 2012- | Indian Institute of Technology Guwahati |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Singh S, Kumari E, Bhardwaj R, et al. (2017) Molecular events leading to death of Leishmania donovani under spermidine starvation after hypericin treatment. Chemical Biology & Drug Design |
Bhardwaj R, Das M, Singh S, et al. (2017) Evaluation of CAAX prenyl protease II of Leishmania donovani as potential drug target: Infectivity and growth of the parasite is significantly lowered after the gene knockout. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences |
Bhardwaj R, Singh SK, Dubey VK. (2016) Subcellular localization studies of LdBPK_070020, a conserved protein of Leishmania donovani. Journal of Vector Borne Diseases. 53: 375-378 |
Bhardwaj R, Kumar R, Singh SK, et al. (2016) Understanding the importance of conservative hypothetical protein LdBPK_070020 in Leishmania donovani and its role in subsistence of the parasite. Archives of Biochemistry and Biophysics |
Singh S, Prabhu SV, Suryanarayanan V, et al. (2015) Molecular docking and structure based virtual screening studies of potential drug target, CAAX prenyl proteases, of Leishmania donovani. Journal of Biomolecular Structure & Dynamics. 1-51 |
Singh S, Sarma S, Katiyar SP, et al. (2015) Probing the molecular mechanism of hypericin-induced parasite death provides insight into the role of spermidine beyond redox metabolism in Leishmania donovani. Antimicrobial Agents and Chemotherapy. 59: 15-24 |